Heart Matters

Since cardiovascular disease is one of the leading causes of death in the U.S., cardiology physicians are continuously working to better understand this common disease and to help patients improve their heart health. And here to assist cardiology physicians in this mission is Heart Matters, a series dedicated to covering essential strategies and research efforts focusing on all types of heart problems, including coronary artery diseases, heart attacks, high cholesterol, high blood pressure, and more.

So whether you’re looking for ways to improve heart health or catch up on the latest cardiology research, you never have to worry about missing a beat thanks to Heart Matters.

658

LikeLikedUnlike

1-15 of 262

Steroidal vs Nonsteroidal MRAs: Implications for Heart Failure Care
Heart Matters
Steroidal vs Nonsteroidal MRAs: Implications for Heart Failure Care
- Steve Jackson, PharmD
- Robert J. Mentz, MD, FHFSA, FACC
Making UACR a Routine Part of Diabetes Care
Heart Matters
Making UACR a Routine Part of Diabetes Care
- Steve Jackson, PharmD
- Robert J. Mentz, MD, FHFSA, FACC
Athlete-Focused CPET: Interpreting Physiology Beyond Standardized Testing
Heart Matters
Athlete-Focused CPET: Interpreting Physiology Beyond Standardized Testing
- Benjamin Levine, MD, FACC
Understanding CPET for Athletes: Protocols and Pitfalls
Heart Matters
Understanding CPET for Athletes: Protocols and Pitfalls
- Benjamin Levine, MD, FACC
Advances in Sports Cardiology: Updates from ACC 2026
Heart Matters
Advances in Sports Cardiology: Updates from ACC 2026
- Jeffrey Hsu, MD, PhD
Supporting Patients With ATTR-CM: Preserving Function and Quality of Life
Heart Matters
Supporting Patients With ATTR-CM: Preserving Function and Quality of Life
- Joban Vaishnav, MD
advertisement
Counseling Patients on Disease Progression in ATTR-CM
Heart Matters
Counseling Patients on Disease Progression in ATTR-CM
- Joban Vaishnav, MD
Rethinking Thromboembolic Risk in ATTR-CM Care
Heart Matters
Rethinking Thromboembolic Risk in ATTR-CM Care
Silencers and Stabilizers in ATTR-CM: Challenging Assumptions
Heart Matters
Silencers and Stabilizers in ATTR-CM: Challenging Assumptions
Heart Failure Hospitalization and Mortality in Cardiac Amyloidosis
Heart Matters
Heart Failure Hospitalization and Mortality in Cardiac Amyloidosis
AI-Driven Advances in ATTR-CM Care
Heart Matters
AI-Driven Advances in ATTR-CM Care
- Frederick Ruberg, MD
Disease-Modifying Advances in ATTR-CM Management
Heart Matters
Disease-Modifying Advances in ATTR-CM Management
advertisement
Hidden HFpEF in Atrial Fibrillation: A Missed Diagnosis with Real Consequences
Heart Matters
Hidden HFpEF in Atrial Fibrillation: A Missed Diagnosis with Real Consequences
Plasma Biomarkers Associated with HF Hospitalization in Atrial Fibrillation
Heart Matters
Plasma Biomarkers Associated with HF Hospitalization in Atrial Fibrillation
FAI and the Future of Cardiac Risk Stratification
Heart Matters
FAI and the Future of Cardiac Risk Stratification